Improved Assay Conditions for Automated Antithrombin III Determinations with the Chromogenic Substrate S-2238

Summary

Assays for antithrombin III activity using the chromogenic substrate S-2238 were automated in various modifications on various instruments. Standard curves for the assay showed a deviating “0% point” in several but not all modifications. Addition of polyethylene glycol 6000/8000 (0.40-1.0%) minimizes this deviation. However, the deviation of the 0% point was not completely abolished in every modification of the test. Examination of Lineweaver-Burk plots showed nonlinearity at high concentrations of S-2238 as used in the antithrombin III assays. Addition of Tween-80 (0.01%) restores the Lineweaver-Burk plot and, at the same time, the standard curve in the assays is found to be linear. Therefore, we recommend the use of PEG 6000/8000 as well as Tween-80 in automated assay systems.

Key words

Antithrombin III - Thrombin - Chromogenic substrates

• References

• 1 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombos Diathes Haemorrh 1965; 13: 516-530
• 2 Ten Cate JW. An automated chromogenic antithrombin III method: clinical experience. In: Synthetic substrates in clinical blood coagulation assays. Lijnen HR, Collen D, Verstraete M. (Eds) Martinus Nijhoff Publishers; The Hague: 1980. pp 45-50
• 3 Schipper HG, Roos J, van der Meulen F, ten Cate JW. Antithrombin III deficiency in surgical intensive care patients. Thromb Res 1981; 21: 73-80
• 4 Blombäck M. Chromogenic substrates in the laboratory diagnosis of clotting disorders. In: Haemostasis and Thrombosis. Bloom AL, Thomas DP. (Eds.) Churchill Livingstone; Edinburgh: 1981. pp 809-823
• 5 Conard J. Automation of Antithrombin III methods on routinely available Instruments. Semin Thromb Haemostas 1983; 9: 263-267
• 6 Friberger P. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates. Semin Thromb Haemostas 1983; 9: 281-300
• 7 Jespersen J, Sidelmann J. Individual levels of plasma α₂-antiplasmin and α₂-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Thromb Haemostas 1983; 50: 581-585
• 8 Odegard OR, Lie M. On use of chromogenic sustrates for studies of coagulation inhibitors. Haemostasis 1978; 7: 121-126
• 9 Odegard OR. Evaluation of an amidolytic heparin cofactor assay method. Thromb Res 1975; 7: 351-360
• 10 Kluft C, van Voorthuizen H. Effects of plasma on the kinetics of chromogenic substrates: consequences for assays of α₂-antiplasmin and antithrombin III. Thromb Haemostas 1983; 50: 268 (Abstr.)
• 11 Handeland GF, Abildgaard U, Aasen AO. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Scand J Haematol 1983; 31: 427-436
• 12 Kahlé LH, Schipper HG, Jenkins CS P, ten Cate JW. Evaluation of an automated antithrombin III method. Thromb Res 1978; 12: 1003-1014
• 13 Wasiewski W, Fasco MJ, Martin BM, Detwiler TC, Fenton JW. Thrombin adsorption to surfaces and prevention with polyethylene glycol 6,000. Thromb Res 1976; 8: 881-886
• 14 Lottenberg R, Jackson CM. Solution composition dependent variation in extinction coefficients for p-nitroaniline. Biochim Biophys Acta 1983; 742: 558-564
• 15 Kluft C, Wijngaards G, van Voorthuizen H. Revised reference curve for the α₂-antiplasmin assay by the addition of detergents. Thromb Haemostas 1984; 51: 297
• 16 Jespersen J, Gram J, Sidelmann J. Modification of the immediate plasmin inhibition assay to secure linearity of the reference curve with the chromogenic substrate S-2251. Thromb Haemostas 1984; 51: 298